Zimmer Biomet Holdings, Inc. (ZBH) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

22/25

Growth 5 Margin 4 Expansion 5 Platform 3 Financial 5

latest quarter score

Earnings Reports

22
Zimmer Biomet (ZBH) Q2 2026: Technology Sales Surge 53%, Accelerating Commercial Transformation
August 05, 2026
16
Zimmer Biomet (ZBH) Q4 2025: U.S. Dedicated Sales Shift Drives 5.4% Organic Growth Amid Channel Overhaul
June 15, 2026
20
Zimmer Biomet (ZBH) Q1 2026: Tariff Benefit Lifts EPS by $0.20, While U.S. Sales Force Overhaul Gains Traction
April 28, 2026
21
Zimmer Biomet (ZBH) Q3 2025: U.S. Growth Accelerates to 5.6% as Innovation Cycle Gains Traction
November 05, 2025
23
Zimmer Biomet (ZBH) Q2 2025: 2.8% Organic Growth Signals Robust New Product Cycle and Strategic M&A Momentum
August 07, 2025
19
Zimmer Biomet (ZBH) Q1 2025: Paragon 28 Adds 270bps Growth, Offsetting Tariff and Margin Headwinds
July 07, 2025

Browse all companies